APA (7th ed.) Citation

Sheetz, M., Barrington, P., Callies, S., Berg, P. H., McColm, J., Marbury, T., . . . Witcher, D. R. (2019). Targeting the hepcidin–ferroportin pathway in anaemia of chronic kidney disease. British journal of clinical pharmacology, 85(5), 935-948. https://doi.org/10.1111/bcp.13877

Chicago Style (17th ed.) Citation

Sheetz, Matthew, et al. "Targeting the Hepcidin–ferroportin Pathway in Anaemia of Chronic Kidney Disease." British Journal of Clinical Pharmacology 85, no. 5 (2019): 935-948. https://doi.org/10.1111/bcp.13877.

MLA (9th ed.) Citation

Sheetz, Matthew, et al. "Targeting the Hepcidin–ferroportin Pathway in Anaemia of Chronic Kidney Disease." British Journal of Clinical Pharmacology, vol. 85, no. 5, 2019, pp. 935-948, https://doi.org/10.1111/bcp.13877.